We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Finger Stick Blood Test Detects Early Signs of Heart Attack Before it Occurs

By LabMedica International staff writers
Posted on 21 Jun 2022
Print article
Image: Micro-device designed to sense blood clots could pick up early signs of heart attack (Photo courtesy of Pexels)
Image: Micro-device designed to sense blood clots could pick up early signs of heart attack (Photo courtesy of Pexels)

Heart attacks and strokes are the world’s leading cause of death. Many are caused by blood clots that block the flow of blood to the heart, often in at-risk individuals without any physical warning. However, long before a heart attack or stroke occurs, tiny changes in the blood begin taking place. Often, blood flow is disturbed, leading to blood clotting and inflammation which can block blood vessels. Now, researchers are developing a biomedical micro-device to detect these subtle platelet changes before a heart attack or stroke takes place.

Using a pin-prick test, the micro-device developed by scientists at the University of Sydney (Sydney, Australia) would take a blood sample from a person’s finger. The sample would then be analyzed for platelet clotting and white cell inflammation responses, information that would be immediately processed by an external operating system. The scientists will undertake further engineering development for the microdevice, which is predicated on an integrated microfluidic chip. The team is also working to build highly sensitive computational fluid dynamics simulations to better understand the impact of mechanical forces that could lead to blood pooling and clots.

“How this device would work is that an at-risk person, for example, someone with heart disease, would use it daily. Using a finger prick test, the device would monitor their blood and alert them to any potentially dangerous changes. If a change was detected, they would need to present for more monitoring at a hospital," said Dr. Arnold Lining Ju, an award-winning biomedical engineer from the University of Sydney's Nano Institute and School of Biomedical Engineering.

Research assistant Laura Moldovan said that, historically, it has been difficult to predict when a heart attack or stroke might happen: “They appear to occur at random, sometimes without any physical symptoms, however in fact there are tiny physical changes that occur in the blood – the key to this device is being able to sensitively monitor these microscopic changes.”

Related Links:
University of Sydney 

Automated ELISA-IFA-BLOT Processor AP 22
Gold Supplier
Benchtop Real-Time PCR Analyzer
Savanna
New
Gold Supplier
Quantitative Immunoassay Analyzer
FIA8000
New
Microplate Incubator Shaker
iShak TS4 NXT

Print article

Channels

Molecular Diagnostics

view channel
Image: A new method reliably detects protein changes in blood that are typical of Parkinson`s disease (Photo courtesy of Pexels)

First-Ever Blood Test Detects Parkinson’s Disease

Until now, the diagnosis of Parkinson's disease has been based primarily on typical movement disorders such as muscle stiffness, slower movements and shaking. However, the disease starts up to 20 years... Read more

Industry

view channel
Image: Fujirebio has acquired ADx NeuroSciences for 40 million Euros (Photo courtesy of Pexels)

Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests

Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.